Asthma Clinical Trials in Philadelphia, Pennsylvania

3 studies are recruiting for asthma in Philadelphia, Pennsylvania right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

    The primary objective of the trial is to evaluate the efficacy of fluticasone propionate/albuterol sulfate multidose dry powder inhaler with electronic module (Fp/ABS eMDPI). Secondary objectives are: * To evaluate the efficacy of Fp/ABS eMDPI administered four times daily * To evaluate the safety …

    Stage
    Phase 3
    Ages
    12 and older
    Site
    Teva Investigational Site 12072, Philadelphia, Pennsylvania
    Locations
    189 in total
    Run by
    Teva Branded Pharmaceutical Products R&D LLC

    See if you can join NCT06664619 on ClinicalTrials.gov

  2. Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids

    This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids.

    Stage
    Phase 2
    Ages
    18 to 75
    Site
    Research Site, Philadelphia, Pennsylvania
    Locations
    221 in total
    Run by
    AstraZeneca

    See if you can join NCT06932263 on ClinicalTrials.gov

  3. Depemokimab Asthma Imaging and Bronchoscopy Sub-Study

    Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and worsen unpredictably.\xa0The purpose of this study is to assess how depemokimab, a monoclonal antibody, affects the structure and function of the lungs in asthmat…

    Stage
    Phase 3
    Ages
    18 and older
    Site
    GSK Investigational Site, Philadelphia, Pennsylvania
    Locations
    50 in total
    Run by
    GlaxoSmithKline

    See if you can join NCT06979323 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.